These studies showed that NOL4 is methylated in 85% of cervical cancers [122] and in 91% HNSCC samples [123] and therefore the analysis of the epigenetic alteration of this gene can be used for early detection and risk prediction of cancers. This evidence concerns the gene NOL4 and head and neck squamous cell carcinoma.